Metraipolis › archive › dc_cf1b2bb64750
Developing Synthetic Full-Length SARS-CoV-2 cDNAs and Reporter Viruses for High-Throughput Antiviral Drug Screening — Europe PMC PMID:41600809
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41600809
- DOI
- 10.3390/v18010044
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T07:41:30.041Z
- SHA-256 of the archived text
201a38f3ae72956987ec47de74805615be5c00de8f9f86751869ecd8d8a3a93c- Stable URL of this page
https://metraipolis.com/documento/dc_cf1b2bb64750
How to cite
Developing Synthetic Full-Length SARS-CoV-2 cDNAs and Reporter Viruses for High-Throughput Antiviral Drug Screening — Europe PMC PMID:41600809 — Europe PMC (en), https://europepmc.org/article/MED/41600809 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf1b2bb64750 (Metraipolis archive dc_cf1b2bb64750, sha256 201a38f3ae72956987ec47de74805615be5c00de8f9f86751869ecd8d8a3a93c)
BibTeX
@misc{dccf1b2bb64750,
title = {Developing Synthetic Full-Length SARS-CoV-2 cDNAs and Reporter Viruses for High-Throughput Antiviral Drug Screening — Europe PMC PMID:41600809},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41600809},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf1b2bb64750; sha256 201a38f3ae72956987ec47de74805615be5c00de8f9f86751869ecd8d8a3a93c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41600809. Agents can read the archived copy with the MCP tool read_document.